GO:0051248 negative regulation of protein metabolic process: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051248 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of chemical reactions and pathways involving a protein.
• It is a broad regulatory node that integrates nutrient sensing, stress signaling, and developmental cues to control protein synthesis and turnover.
• Key molecular brakes include the Hippo kinase cassette (STK3/STK4-LATS1/LATS2) that restricts YAP/TAZ-driven protein synthesis and MAPK-dependent inhibition of amino acid signaling through 4F2hc/Girdin.
• The Rcs phosphorelay and Maf1 are conserved negative regulators of protein metabolism in bacteria and eukaryotes, respectively.
• Dysregulation of this process contributes to cancer, metabolic disorders, and neurodegeneration, making it a high-value target for CRISPR functional genomics.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise dissection of negative regulatory circuits in this GO term.
Description
The Gene Ontology term GO:0051248, negative regulation of protein metabolic process, captures a fundamental layer of cellular control: the mechanisms that restrain the production, modification, and degradation of proteins. Because protein metabolism consumes a large fraction of cellular energy and determines the proteome landscape, its negative regulation is essential for homeostasis, stress adaptation, and developmental decisions. Researchers studying this term ask how kinases, phosphatases, and nutrient sensors converge to dampen translation, folding, or turnover when conditions demand it. The breadth of GO:0051248 means it intersects with nearly every signaling pathway, from the Hippo pathway in metazoans to the Rcs phosphorelay in bacteria. Understanding these brakes is clinically relevant because their failure can drive uncontrolled proliferation or proteotoxic stress. This article synthesizes authoritative QuickGO annotations and verified PubMed literature to provide a research-grade overview of the mechanisms, genes, and experimental models used to study negative regulation of protein metabolic process.
negative regulation of protein metabolic process At A Glance
| GO ID | GO:0051248 |
|---|---|
| GO term | negative regulation of protein metabolic process |
| Ontology | biological_process |
| Synonym | down regulation of protein metabolic process; inhibition of protein metabolic process; negative regulation of cellular protein metabolic process |
| Major function | Restrains the frequency, rate, or extent of protein synthesis, modification, and degradation |
| Related processes | Negative regulation of translation, protein catabolism, and amino acid signaling |
| Key regulators | Hippo kinases (STK3/STK4, LATS1/LATS2), MAPK-4F2hc/Girdin, Maf1, Rcs phosphorelay |
| Disease relevance | Cancer, metabolic disorders, neurodegeneration, and bacterial pathogenesis |
What Is GO:0051248?
In our own words, GO:0051248 encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of chemical reactions and pathways involving a protein. This includes negative regulation of protein synthesis (translation), protein folding, post-translational modification, and protein catabolism. It is a biological_process term that acts as a parent to more specific negative regulation terms, and it is defined by its outcome rather than by a single molecular mechanism.
Why Is negative regulation of protein metabolic process Important in Cell Biology?
Negative regulation of protein metabolic process is important because it sets the threshold for proteome remodeling under stress, nutrient limitation, and developmental transitions. Without these brakes, cells risk energy exhaustion, accumulation of misfolded proteins, or uncontrolled growth. The Hippo pathway exemplifies how negative regulation of protein metabolism suppresses oncogenic YAP/TAZ activity, while MAPK-dependent inhibition of amino acid signaling through 4F2hc/Girdin fine-tunes nutrient uptake. In bacteria, the Rcs phosphorelay negatively regulates protein metabolism to coordinate envelope stress responses. Thus, GO:0051248 is a central node for understanding both normal physiology and disease.
• Controls protein synthesis and turnover to maintain proteostasis under stress.
• Integrates nutrient and energy signals to prevent wasteful anabolism.
• Restrains oncogenic pathways such as YAP/TAZ-driven proliferation.
• Modulates immune and inflammatory responses through amino acid transporters.
• Regulates bacterial virulence and envelope stress via the Rcs phosphorelay.
• Impacts muscle protein metabolism during negative energy balance.
• Influences RNA polymerase III transcription and tRNA production via Maf1.
• Provides targets for CRISPR screens to identify novel growth suppressors.
• Links histone acetylation and secondary metabolite biosynthesis in fungi.
• Offers therapeutic entry points for cancer, metabolic disease, and neurodegeneration.
What Happens During negative regulation of protein metabolic process?
Initiation of negative regulation by stress and nutrient signals
In simple terms: When cells face stress or low nutrients, they activate brakes on protein production.
Negative regulation of protein metabolic process is often initiated by environmental or metabolic cues. Salt stress in Arabidopsis activates the CDK8-AHL10-SUVH2/9 module to dynamically regulate salt tolerance, which includes negative regulation of protein metabolism-related genes. In mammalian cells, amino acid availability is sensed by pathways that can inhibit protein synthesis through MAPK-regulated 4F2hc/Girdin complexes. The Hippo pathway kinases STK3/STK4 and LATS1/LATS2 are activated by cell density and stress, leading to negative regulation of YAP/TAZ-driven protein synthesis. These examples show that initiation involves upstream sensors and kinases that phosphorylate downstream effectors.
Signal transduction to translational machinery
In simple terms: The brake signal is passed to the machinery that makes proteins.
Once activated, negative regulatory signals converge on the translational apparatus. Maf1 is a conserved repressor of RNA polymerase III transcription, reducing tRNA and 5S rRNA production, which indirectly limits protein synthesis. The Hippo pathway effector LATS1/LATS2 phosphorylates YAP/TAZ, causing their cytoplasmic retention and reducing transcription of pro-growth genes. MAPK signaling can inhibit amino acid signaling through 4F2hc/Girdin, dampening mTORC1-dependent translation. These transduction events ensure that protein metabolism is slowed when conditions are unfavorable.
Effector mechanisms: inhibition of translation and protein stability
In simple terms: The cell actually slows down protein building and speeds up protein breakdown.
Effector mechanisms include inhibition of translation initiation, elongation, and termination, as well as enhanced protein degradation. The Rcs regulatory cascade in bacteria negatively regulates protein metabolism by controlling genes involved in envelope stress and metabolism. In skeletal muscle, negative energy balance and dietary protein intake modulate protein synthesis and breakdown, illustrating physiological negative regulation. Histone acetylation modifications in fungi regulate secondary metabolite biosynthesis, which is linked to protein metabolic processes. These effectors ultimately reduce the frequency or rate of protein metabolic reactions.
Feedback and resolution of negative regulation
In simple terms: The brakes are released when conditions improve.
Negative regulation is dynamic and reversible. The CDK8-AHL10-SUVH2/9 module dynamically regulates salt tolerance, implying feedback loops that adjust the strength of negative regulation. Amino acid signaling pathways are subject to feedback inhibition by MAPK-regulated 4F2hc/Girdin, which can be relieved when nutrients are restored. The Hippo pathway is regulated by upstream polarity and junctional cues, allowing rapid changes in YAP/TAZ activity. Maf1 activity is controlled by phosphorylation and nutrient status, enabling recovery of RNA polymerase III transcription. Thus, resolution ensures that protein metabolism resumes when stress subsides.
Key Genes Involved in GO:0051248 negative regulation of protein metabolic process
The following genes and proteins are experimentally validated participants in negative regulation of protein metabolic process, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STK3/STK4 | Hippo pathway kinases that activate LATS1/LATS2 | Negative regulation of YAP/TAZ-driven protein synthesis |
| LATS1/LATS2 | Phosphorylate YAP/TAZ to restrict protein metabolism | Core tumor suppressors in Hippo signaling |
| YAP/TAZ | Transcriptional co-activators of pro-growth genes | Targets of negative regulation; oncogenic when unrestrained |
| MAPK | Kinase that inhibits amino acid signaling via 4F2hc/Girdin | Links nutrient sensing to negative regulation |
| 4F2hc/Girdin | Amino acid transporter complex regulated by MAPK | Negative regulation of amino acid signaling |
| Maf1 | Repressor of RNA polymerase III transcription | Limits tRNA and rRNA synthesis |
| Rcs phosphorelay | Bacterial two-component system | Negative regulation of protein metabolism in envelope stress |
| CDK8 | Kinase module of Mediator complex | Regulates salt tolerance and protein metabolism genes |
| AHL10 | Plant-specific protein in CDK8 module | Dynamic regulation of salt tolerance |
| SUVH2/9 | Histone methyltransferases | Chromatin-level negative regulation |
| mTORC1 | Nutrient-sensing kinase complex | Central regulator of protein synthesis |
| GCN2 | Amino acid deprivation sensor | Activates integrated stress response |
| eIF2alpha | Translation initiation factor | Phosphorylation inhibits global translation |
| Histone acetyltransferases | Modify chromatin to regulate gene expression | Linked to secondary metabolite biosynthesis |
| Histone deacetylases | Remove acetyl groups from histones | Negative regulation of protein metabolism genes |
How Is negative regulation of protein metabolic process Regulated?
Negative regulation of protein metabolic process is itself regulated at multiple levels. Upstream, nutrient sensors such as mTORC1 and GCN2 detect amino acid availability and energy status, modulating translation initiation and the integrated stress response. The Hippo pathway kinases STK3/STK4 and LATS1/LATS2 are controlled by cell polarity, junctional complexes, and mechanical cues, providing spatial regulation. MAPK signaling can phosphorylate 4F2hc/Girdin to inhibit amino acid signaling, adding another layer of control. In bacteria, the Rcs phosphorelay is activated by envelope stress and regulates downstream targets. Maf1 activity is modulated by phosphorylation in response to nutrient and stress signals. These regulatory inputs ensure that negative regulation is context-dependent and reversible.
negative regulation of protein metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STK3/STK4 | Cancer (Hippo pathway tumor suppressors) | Knockout in cancer cell lines; xenograft models |
| LATS1/LATS2 | Cancer, developmental disorders | Point mutation knock-in to disrupt kinase activity |
| 4F2hc/Girdin | Metabolic disorders, cancer | Overexpression and knockout in mammalian cells |
| Maf1 | Cancer, metabolic stress | Knockout and rescue in yeast and human cells |
| Rcs phosphorelay | Bacterial pathogenesis | Deletion mutants in E. coli and Salmonella |
Cancer
Loss of negative regulation of protein metabolic process can drive oncogenesis. Inactivation of Hippo pathway kinases STK3/STK4 or LATS1/LATS2 leads to YAP/TAZ hyperactivation, promoting uncontrolled protein synthesis and proliferation. MAPK-dependent inhibition of 4F2hc/Girdin is important for restraining amino acid signaling, and its dysregulation may contribute to metabolic reprogramming in cancer. Targeting these negative regulatory nodes is a promising therapeutic strategy.
Metabolic disorders
Negative energy balance and dietary protein intake affect skeletal muscle protein metabolism, and impaired negative regulation can lead to muscle wasting or metabolic syndrome. Amino acid signaling pathways that are negatively regulated by MAPK-4F2hc/Girdin are critical for maintaining metabolic homeostasis. Dysregulation of mTORC1 and GCN2 pathways contributes to insulin resistance and obesity.
Neurodegeneration
Proteotoxic stress is a hallmark of neurodegenerative diseases. Negative regulation of protein metabolic process helps clear misfolded proteins, and its failure can exacerbate neuronal death. The integrated stress response, which inhibits global translation via eIF2alpha phosphorylation, is a key protective mechanism that becomes dysregulated in neurodegeneration.
Infectious disease
Bacterial pathogens use the Rcs phosphorelay to negatively regulate protein metabolism during envelope stress, which is important for virulence. Understanding these bacterial brakes may inform new antibiotic strategies.
From negative regulation of protein metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of STK3/STK4 increase protein synthesis? | CRISPR knockout in HEK293T or MCF10A cells |
| Does a specific LATS1 point mutation abolish YAP phosphorylation? | Point mutation knock-in via CRISPR |
| Can tagged 4F2hc/Girdin reveal dynamic MAPK-dependent regulation? | Knock-in of epitope tag at endogenous locus |
| Does Maf1 overexpression reduce tRNA levels? | Overexpression in yeast or human cells |
| Is the Rcs phosphorelay required for envelope stress survival? | Deletion mutants in E. coli |
| Does CDK8 inhibition alter salt tolerance? | CRISPR knockout in Arabidopsis |
How to Study the negative regulation of protein metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Translation efficiency and ribosome occupancy | Global negative regulation of protein synthesis |
| RNA-seq | mRNA abundance and splicing | Transcriptional changes in response to stress |
| Proteomics | Protein abundance and modifications | Protein turnover and post-translational regulation |
| Phosphoproteomics | Kinase substrate phosphorylation | Mapping signaling cascades that inhibit protein metabolism |
| Polysome profiling | Distribution of mRNAs across polysomes | Translation initiation and elongation control |
| Western blot | Specific protein levels and phosphorylation | Validation of candidate negative regulators |
| Luciferase reporter | Transcriptional activity of target promoters | YAP/TAZ or Maf1-dependent transcription |
| CRISPR screens | Gene essentiality and pathway interactions | Discovery of novel negative regulators |
Ribosome profiling (Ribo-seq)
Ribo-seq measures translation efficiency genome-wide by sequencing ribosome-protected mRNA fragments. It is ideal for quantifying negative regulation of protein synthesis under stress or nutrient limitation.
RNA-seq and transcriptomics
RNA-seq reveals changes in mRNA abundance that may result from negative regulation of transcription or mRNA stability. It is often combined with Ribo-seq to distinguish transcriptional from translational control.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics quantifies protein abundance and post-translational modifications, directly measuring the output of protein metabolic processes. Phosphoproteomics identifies signaling events that mediate negative regulation.
Imaging and reporter assays
Fluorescent reporters of translation (e.g., SunTag) and live-cell imaging can visualize negative regulation in real time. Immunofluorescence for YAP/TAZ localization is a classic readout of Hippo pathway activity.
How CRISPR Can Be Used to Study GO:0051248 negative regulation of protein metabolic process
Knockout
CRISPR knockout is used to delete negative regulators such as STK3/STK4 or LATS1/LATS2 to assess their role in restraining protein metabolism. In bacteria, deletion of Rcs phosphorelay components reveals their contribution to envelope stress survival. Knockout of Maf1 in yeast increases tRNA synthesis, confirming its repressive function.
Point Mutation
Point mutations can be introduced to dissect specific phosphorylation sites or catalytic residues. For example, kinase-dead mutations in LATS1 or STK3 can test whether catalytic activity is required for negative regulation of YAP/TAZ. Similarly, mutations in 4F2hc/Girdin can identify MAPK phosphorylation sites that mediate inhibition of amino acid signaling.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous loci enables real-time tracking of negative regulators. Tagging Maf1 or 4F2hc/Girdin allows immunoprecipitation and imaging without overexpression artifacts. Knock-in of reporter cassettes can also monitor transcriptional responses to stress.
Overexpression
Overexpression of negative regulators such as Maf1 or LATS1 can suppress protein synthesis and proliferation, providing gain-of-function evidence. In plant systems, overexpression of CDK8-AHL10-SUVH2/9 components can alter salt tolerance. Overexpression models are useful for testing sufficiency of a candidate brake.
How EDITGENE Supports negative regulation of protein metabolic process Research
Researchers studying negative regulation of protein metabolic process-related genes often need to determine whether a candidate gene is causally involved in restraining protein synthesis, folding, or degradation. This requires precise genetic models that can isolate the contribution of a single gene or mutation. EDITGENE provides end-to-end CRISPR services to generate such models efficiently and reproducibly.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of protein metabolic process research.
Frequently Asked Questions About negative regulation of protein metabolic process
What is GO:0051248 negative regulation of protein metabolic process?
It is a Gene Ontology biological process term describing any process that stops, prevents, or reduces the frequency, rate, or extent of chemical reactions and pathways involving a protein.
What genes are involved in negative regulation of protein metabolic process?
Key genes include STK3, STK4, LATS1, LATS2, YAP, TAZ, MAPK, 4F2hc/Girdin, MAF1, and the Rcs phosphorelay components.
How is negative regulation of protein metabolic process studied?
Common methods include Ribo-seq, RNA-seq, proteomics, phosphoproteomics, polysome profiling, and CRISPR screens.
Why is negative regulation of protein metabolic process important in cancer?
Loss of negative regulators such as LATS1/LATS2 leads to YAP/TAZ hyperactivation and uncontrolled protein synthesis, promoting tumor growth.
What is the role of Maf1 in negative regulation of protein metabolic process?
Maf1 represses RNA polymerase III transcription, reducing tRNA and 5S rRNA synthesis, which indirectly limits protein production.
How does the Hippo pathway negatively regulate protein metabolism?
The Hippo kinases STK3/STK4 phosphorylate LATS1/LATS2, which then phosphorylate YAP/TAZ, causing their cytoplasmic retention and reducing pro-growth gene expression.
What is the Rcs phosphorelay?
The Rcs phosphorelay is a bacterial two-component system that negatively regulates protein metabolism in response to envelope stress.
Can CRISPR be used to study negative regulation of protein metabolic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect these regulatory pathways.
What diseases are linked to dysregulated negative regulation of protein metabolic process?
Cancer, metabolic disorders, neurodegeneration, and infectious diseases have been linked to dysregulation of this process.
How does EDITGENE support research on GO:0051248?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to study negative regulation of protein metabolic process.
Conclusion
GO:0051248 negative regulation of protein metabolic process is a central regulatory node that integrates nutrient, stress, and developmental signals to control protein synthesis and turnover. Its dysregulation contributes to cancer, metabolic disorders, and neurodegeneration, making it a high-priority area for functional genomics. CRISPR-based models and multi-omics methods now enable precise dissection of these pathways. EDITGENE offers comprehensive services to accelerate discovery in this field.
References
- 1. Guo P et al.. 2025. Salt stress activates the CDK8-AHL10-SUVH2/9 module to dynamically regulate salt tolerance in Arabidopsis.. Nat Commun 16(1):2454 PMID: 40074748
- 2. Avruch J et al.. 2012. Protein kinases of the Hippo pathway: regulation and substrates.. Semin Cell Dev Biol 23(7):770-84 PMID: 22898666
- 3. Wall E et al.. 2018. The Complex Rcs Regulatory Cascade.. Annu Rev Microbiol 72:111-139 PMID: 29897834
- 4. Weng L et al.. 2018. Negative regulation of amino acid signaling by MAPK-regulated 4F2hc/Girdin complex.. PLoS Biol 16(3):e2005090 PMID: 29538402
- 5. Carbone JW et al.. 2012. Skeletal muscle responses to negative energy balance: effects of dietary protein.. Adv Nutr 3(2):119-26 PMID: 22516719
- 6. Cieśla M et al.. 2008. Regulation of RNA polymerase III transcription by Maf1 protein.. Acta Biochim Pol 55(2):215-25 PMID: 18560610
- 7. Yan L et al.. 2011. Signalling by amino acid nutrients.. Biochem Soc Trans 39(2):443-5 PMID: 21428916
- 8. Hou X et al.. 2024. Regulation of Histone Acetylation Modification on Biosynthesis of Secondary Metabolites in Fungi.. Int J Mol Sci 26(1) PMID: 39795886
